Huldrych F Günthard
Huldrych F Günthard is an expert in Infectiology at University Hospital of Zurich (Switzerland). Huldrych F Günthard has authored 802 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 2,107 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Pharmacy - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 802
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Chronic alanine aminotransferase elevation in people with HIV: Time trends over 22 years and genetic predisposition. PMID 42860594 — alanine transaminase, tenofovir, alanine, genetic predisposition to disease, transaminases, prevalence, risk factors, genetic background, genetic risk score | HIV Med | 2026 | 0 |
| Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND. PMID 42609932 — cardiovascular diseases, integrase inhibitors, therapeutics, integrases | Open Forum Infect Dis | 2026 | 0 |
| Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People With HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study. PMID 42582508 — stroke, myocardial infarction, cardiovascular diseases, cohort studies, integrase inhibitors, therapeutics, integrases | Open Forum Infect Dis | 2026 | 0 |
| Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025. PMID 42578097 — cohort studies, integrase inhibitors, cluster analysis, integrases | Open Forum Infect Dis | 2026 | 0 |
| Epidemiology and Clinical Impact of Clonal Hematopoiesis in People with HIV. PMID 42518217 — genes, epidemiology, hematopoiesis, neoplasms, clonal hematopoiesis, hiv, prevalence, communicable diseases | J Infect Dis | 2026 | 0 |
Clinical Studies 18
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 194
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Reduce Tobacco Use in People Living With HIV in Switzerland NCT06789692 — tobacco smoking, cohort studies, vaping, hiv, physicians, tobacco use, nicotine, smoking | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map